controle de qualidade em radiofármacos

Upload: itala-souza

Post on 07-Jul-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/19/2019 Controle de qualidade em Radiofármacos

    1/8

    UNIVERSIDADE FEDERAL DO MARANHÃO

    CENTRO DE CIÊNCIAS BIOLÓGICAS E DA SAÚDE

    DEPARTAMENTO DE FARMÁCIA

    DISCIPLINA: RADIOISÓTOPOS

    CONTROLE DE QUALIDADE DE RADIOFÁRMACOS

    ÍTALA SOUZA

    JOÃO BATISTA

     NAYANA SUSAN

    SÃO LUÍS

    !"#

  • 8/19/2019 Controle de qualidade em Radiofármacos

    2/8

    1- INTRODUÇÃO

    R$%&'()*+$,'- -.' /-0*101*$- +'2/,12$*/- '1 ,/212$*/- 31/ $4*/-/50$+ /+ -1$

    ,'+4'-&6.' 1+ *$%&'51,27%/' / -.' 10&2&8$%'- 5' %&$95-0&,' '1 0*$0$+/50' %/ %'/56$-

    /+ -/*/- ;1+$5'-< U+$ =/8 31/ '- +/-+'- -.' $%+&5&-0*$%'- /+ ;1+$5'- >&+4'*0$50/ / 5/,/--)*&' 31/ '- +/-+'- 4$--/+ 4'* *&9'*'-' ,'50*'2/ %/ 31$2&%$%/<

    2- CONTROLES DE QUALIDADE

     O ,'50*'2/ %/ 31$2&%$%/ $%/31$%' %/ *$%&'()*+$,'- /5='2=/ $5)2&-/- /+ 57=/2

    (7-&,' / (7-&,'?317+&,'@ 317+&,'@ &'29&,' / %/ /-0$&2&%$%/<

    2.1- Controle de qualidade !"i#o e !"i#o-qu!$i#o

    E+ */2$6.' $'- ,'50*'2/- (7-&,' / (7-&,'?317+&,' -.' ,'5-&%/*$%'-@ ' $-4/,0'(7-&,' 31/ /5='2=/ $5)2&-/- '*9$5'2>40&,$- 0$&- ,'+' ,'*@ 2&+4&%/8 '1 01*&%/8 %$

    -'216.' / $1-5,&$ '1 4*/-/56$ %/ 4$*07,12$- /+ -1-4/5-.' 4$*$ -'216/- '1 /+

    %&-4/*-/- ,'2'&%$&- */-4/,0&=$+/50/@ $ %/0/*+&5$6.' %' 0$+$5;' %$-

     4$*07,12$- (&20*$6.' $0*$=>- %/ +/+*$5$-@ (&20*$6.' /+ 9/2@ /-4$2;$+/50' %$ *$%&$6.'

    2$-/* '1 +&,*'-,'4&$ /2/0*5&,$@ -/5%' 5/,/--)*&$ $4/5$- 4$*$ *$%&'()*+$,'- ,'2'&%$&-

    +T,?SC?/5(*/ ,'2'&%$2@ +TC?MAA?+$,*'$9*/9$%' %/ $21+&5$ / +T,?

    SS?-12(/0' %/ $50&+5&' /+ /-01%'- %/ 4/*(1-.' 412+'5$*@ '0/56.' %/ &+$9/+ %'(79$%' / 2&5(',&50&2'9*$(&$<

    A %/0/*+&5$6.' %' 0$+$5;' %$- 4$*07,12$- 4'%/ -/* /(/01$%$ 4'* (&20*$6.' $0*$=>-

    %/ +/+*$5$- / (&20*$6.' /+ 9/2@ /-4$2;$+/50' %$ *$%&$6.' 2$-/* '1 +&,*'-,'4&$

    /2/0*5&,$@ ' 4H %' *$%&'()*+$,' 31/ %/=/ -/* ' +$&- 4*&+' 4'--7=/2 %' 4H

    (&-&'29&,' 4HK / 4'%/ -/* +/%&%' /+ 4H +/0*' '1 /+ 4$4/2@ $ &-'0'5&,&%$%/ 4$*$

    &5/0)=/&- > ,'5-&%/*$%$ $ &-'0'5&,&%$%/ /+ */2$6.' $' -'*' -$59175/' / $ ('*6$ &5&,$

    %/0/*+&5$%$ 4'* ,'5%10&+/0*&$< D/-=&'- 4'%/+ -/* ,'**&9&%'- 4'* $%&6.' %/ ),&%'-@

     $-/- '1 /2/0*2&0'- /+ 9/*$2@ $ ,$2&*$6.' %$ $0&=&%$%/ 31/ > $ %/0/*+&5$6.' %$

    $0&=&%$%/ 4*/-/50/ /+ 1+$ 4*/4$*$6.' *$%&'($*+$,10&,$@ */$2&8$%$ ,'+ 1+

    /31&4$+/50' $4*'4*&$%' 4$*$ +/5-1*$* ' 0&4' / $ /5/*9&$ %$ *$%&$6.' /+&0&%$< C'+' '

    *$%&'()*+$,' > $%+&5&-0*$%' /+ -/*/- ;1+$5'-@ /-0/ &0/+ > %/ (15%$+/50$2 &+4'*05,&$

    $ (&+ %/ -/ /=&0$* /**'- 5$ $%+&5&-0*$6.' %/ %'-/-< D'-/ > $ $0&=&%$%/ %' *$%&'()*+$,'

    $ -/* $%+&5&-0*$%$ /+ 1+ 4$,&/50/@ 4'%/5%' /-0$ -/* /4*/--$ /+ B3 C& '1 MB3

    +C&< A $0&=&%$%/ %'- *$%&'()*+$,'- /+&--'*/- %/ *$%&$6.' 9$+$ -.' +/%&%$- /+

    ,+$*$- %/ &'5&8$6.' ,$2&*$%$- ,'+ 4$%*/- $%/31$%'-@ %/ $0&=&%$%/- ,'5;/,&%$- /

  • 8/19/2019 Controle de qualidade em Radiofármacos

    3/8

    9/'+/0*&$- %/(&5&%$- 0$&- ,'+' C'?! / C'?K< A ,'5,/50*$6.' %$ $0&=&%$%/ > $

    $0&=&%$%/ ,'50&%$ 4'* 15&%$%/ %/ ='21+/@ -/5%' /4*/--$ /+ B3+2 C&+2 '1

    MB3+2 +C&+2@ -/5%' "+C& K MB3<

    A $0&=&%$%/ /-4/,7(&,$ > $ $0&=&%$%/ 4'* 15&%$%/ %/ +$--$ %' /2/+/50' '1 %$

    ('*+$ 317+&,$ 4*/-/50/@ -/5%' /4*/--$ /+ MB3+9< &+4'*0$50/ $ %/0/*+&5$6.'

    %$- &+41*/8$- *$%&'51,7%&,$- 31/ '*&9&5$+?-/ %' 4*',/--' %/ 4*'%16.' %'

    *$%&'51,27%/'@ 0$&- ,'+' &+41*/8$- &-'04&,$- %' +$0/*&$2 $2='@ 41*&(&,$6.' &5/(&,&/50/

    5$ -/4$*$6.' %/ 1+ 4*'%10' %/ (&--.' /+ */$0'*/-@ $--&+ ,'+' %$ 31/*$ %$ ,'215$ /+

    9/*$%'*/- '1 %/ -14*'%10'- '*&9&5$%'- 4'* %/,$&+/50' *$%&'$0&='< A %/0/*+&5$6.' %$

     41*/8$ *$%&'51,27%&,$ > */$2&8$%$ ,'+ $ %/0/*+&5$6.' %$ +/&$ =&%$ (7-&,$ T" / %$

    *$%&$6.' ,$*$,0/*7-0&,$ 9 '1 < A 4*&+/&*$ 4'%/ -/* +/%&%$ /+ 1+ ,&50&2$%'* -2&%' /

    $ *$%&$6.' 4'%/ -/* +/%&%$ /+ 1+ ,&50&2$%'* 2731&%' '1 /+ 1+ /-4/,0*+/0*'< A-

    &+41*/8$- *$%&'51,27%&,$- ,$1-$+ /4'-&6.' %' 4$,&/50/ $ *$%&$6/- &5%/-/$%$-@

    /=/501$2 0'&%/8 / 4*/178' %$ &+$9/+ ,&50&2'9*)(&,$<

    2.2- Controle de qualidade qu!$i#o

    E+ */2$6.' $' ,'50*'2/ 317+&,' -.' */$2&8$%$- $- %/0/*+&5$6/- %/ 41*/8$

    317+&,$ / *$%&'317+&,$< A 41*/8$ 317+&,$ 4'%/ -/* %/(&5&%$ ,'+' $ (*$6.' %' +$0/*&$2

    5$ ('*+$ 317+&,$ %/-/$%$< A- &+41*/8$- 317+&,$- '*&9&5$+?-/ %/ */$9/50/- &+41*'-'1 31/ 0/5;$+ -'(*&%' %/,'+4'-&6.'@ '1 $&5%$ %/ &+41*/8$- &50*'%18&%$- $0*$=>- %'

     4*4*&' 4*',/--' %/ 41*&(&,$6.'@ ,'+' '- $%-'*=/50/- 10&2&8$%'- /+ ,*'+$0'9*$(&$@ 0$2

    ,'+' $ 4*/-/56$ %/ A2 5' /21$0' %/ +T,@ '1 &+41*/8$- 9/*$%$- 4/2' +$0/*&$2

    10&2&8$%' 5$ /+$2$9/+ %' 4*'%10' (&5$2< A 4*/-/56$ %/--$- &+41*/8$- $50/- %$

    *$%&'+$*,$6.' 4'%/ */-120$* /+ +$*,$6.' &5%/-/$%$ %/ +'2>,12$- 31/ 4'%/+ '1 5.'

    $20/*$* ' ,'+4'*0$+/50' (7-&,'?317+&,' /'1 &'29&,' %$ 4*/4$*$6.'@ &50/*(/*&* 5'

    %&$95-0&,' '1 ,$1-$* $291+ /(/&0' 0&,'< A I%/50&(&,$6.' %/--$- &+41*/8$- 0$+>+

     4'%/ -/* */$2&8$%$ 4'* +>0'%'- ,'2'*&+>0*&,'- / /-4/,0*'('0'+>0*&,'- / $- +/-+$-

     4'%/+ -/* /0*$7%$- 4'* 0>,5&,$- %/ (*$,&'5$+/50' 4*/,&4&0$6.'@ /0*$6.' 4'* -'2=/50/-@

    0*',$ &5&,$@ %/-0&2$6.' / '10*'-<

    A 41*/8$ *$%&'317+&,$ > $ (*$6.' %' *$%&'51,27%/' 4*/-/50/ 5$ ('*+$ 317+&,$

    %/0/*+&5$%$ %' *$%&'()*+$,'< A- &+41*/8$- ','**/+ %/=&%' $ %/,'+4'-&6.' 4'* $6.'

    %' -'2=/50/@ +1%$56$- 5$ 0/+4/*$01*$@ 4H@ 218@ 4*/-/56$ %/ $9/50/- */%10'*/-@

    '&%$50/- / *$%&2&-/ %$ )91$ 4'* $-'*6.' %$ /5/*9&$ /+&0&%$@ 9/*$5%' $ ('*+$6.' %/

     4/*&%' %/ ;&%*'95&' / *$%&,$&- 2&=*/-@ 31/ 9/*$+@ 4'* -1$ =/8@ $ %/,'+4'-&6.' %/

  • 8/19/2019 Controle de qualidade em Radiofármacos

    4/8

    '10*$- +'2>,12$- +$*,$%$-< C'+' &+41*/8$- *$%&'317+&,$- 4'%/+ -/* ,&0$%'- '

     N$+T,O# / ' +T,O /+ ,'+42/'- +$*,$%'- ,'+ +T,< A- &+41*/8$-

    *$%&'317+&,$- 0$+>+ ,$1-$+ $&$ 31$2&%$%/ %$ &+$9/+< A (&+ %/ /=&0$* $

    %/9*$%$6.' %'- *$%&'()*+$,'- / 4$*$ +$50/* $ -1$ /-0$&2&%$%/ -.' 10&2&8$%'-

    ,'5-/*=$50/- ),&%' $-,*&,'@ -12(&0' %/ -%&' / '10*'-< O *$%&'()*+$,' 0$+>+ %/=/

    -/* +$50&%' $' $*&9' %$ 218 / -' */(*&9/*$6.'< A- &+41*/8$- *$%&'317+&,$- 4'%/+ -/* 

    %/0/*+&5$%$- 4'* %&(/*/50/- +>0'%'- $5$270&,'-< A 4*/,&4&0$6.' 4$*$ %/0/*+&5$6.'

    %/ "C*/+ -'216/- %/ N$"C*O# *$%&'()*+$,' 10&2&8$%' 5$ +$*,$6.' %/

    ;/+),&$- 4$*$ %/0/*+&5$6.' %/ -1$ 0$$ %/ -'*/=&%$@ ' ,*'+$0' > 4*/,&4&0$%' ,'+'

    PC*O# / $ *$%&'$0&=&%$%/ %$ -'216.' -'*/5$%$50/ > ,'50$%$ /+ ,&50&2$%'* A

    %/0/*+&5$6.' %/ "C* > &+4'*0$50/ 4'&- ' +/-+' 5.' -/ ,'+42/$ ,'+ $- 4*'0/75$-

    ,/212$*/-< A ,*'+$0'9*$(&$ %/ 4$4/2 / ,*'+$0'9*$(&$ %/ ,$+$%$ (&5$ 31/ -.' 0>,5&,$- %/

    -/4$*$6.' 5$- 31$&- '- ,'+4'5/50/- %' *$%&'()*+$,' +&9*$+ +$&- '1 +/5'- /+ (156.'

    %/ -1$ +$&'* $(&5&%$%/ ,'+ ' /21/50/ ($-/ +=/2 '1 ,'+ $ ($-/ /-0$,&'5)*&$

    */-4/,0&=$+/50/< N'- *$%&'()*+$,'- +$*,$%'- ,'+ ' +T,@ $2>+ %' 4*4*&'

    *$%&'()*+$,'@ 4'%/+ -/* &%/50&(&,$%'- / 31$50&(&,$%'- ' N$+T,O# 2&=*/ /

    ' +T,O< A ,*'+$0'9*$(&$ 9/2 -/4;$%/ 31/ > 1+$ 0>,5&,$ 31/ -/ 10&2&8$ %$

    %&(/*/56$ %/ 0$+$5;' %$- +'2>,12$- 5$ -/4$*$6.' %/ ,'+4'5/50/- %/ 1+$ $+'-0*$@ $-

    +'2>,12$- +$&'*/- -/5%' /217%$- 4*&+/&*' / $- +/5'*/- (&,$5%' */0&%$- 5'- 4'*'- %$

    */-&5$<

    A *$%&'$0&=&%$%/ > +/%&%$ 5$- (*$6/- */,'2;&%$-@ -/5%' /4*/--$ ,'+' 1+

     4/*,/501$2 %$ *$%&'$0&=&%$%/ 0'0$2< A /2/0*'('*/-/ /+ 4$4/2 '1 9/2 %/ 4'2&$,*&2$+&%$@

    0>,5&,$ %/ -/4$*$6.' '5%/ $- %&(/*/50/- /-4>,&/- +'=&+/50$+?-/ /+ (156.' %/ -/1

    0$+$5;'@ -1$ ,$*9$@ PH@ =&-,'-&%$%/@ &50/5-&%$%/ %/ ,'**/50/ / ='20$9/+ $42&,$%$< A

    %&-0*&1&6.' %$ $0&=&%$%/ > %/0/*+&5$%$ /+ 1+ ,'50$%'* '1 -,$55/* 

    *$%&',*'+$0'9*)(&,'< A 0>,5&,$ %/ 41*&(&,$6.' 4'* */-&5$ %/ 0*',$ &5&,$@ /5='2=/ $ 0*',$%/ &'5- /50*/ $ -'216.' $ -/* $5$2&-$%$ / $ */-&5$@ ,'+ */0/56.' %'- 4*&+/&*'- 5'- 4'*'-

    %$ */-&5$ < E-0$ 0>,5&,$ 4'%/ -/* 10&2&8$%$ 4$*$ $ -/4$*$6.' %/ $21+&5$ +$*,$%$

    ,'+ +T, %$- -1$- &+41*/8$- *$%&'317+&,$-@ -/5%' ' +T,O#? 2&=*/ $%-'*=&%' 4/2$

    */-&5$ $5&5&,$@ /531$50' 31/ ' *$%&'()*+$,' / ' ;&%*'2&8$%' %/ +T, -.' /217%'- ,'+

    -$2&5$<

    A /0*$6.' 4'* -'2=/50/ $-/&$?-/ 5$ %&-0*&1&6.' %' -'210' /+ %'&- -'2=/50/-

    &+&-,7=/&-@ 9/*$2+/50/ )91$ / 1+ -'2=/50/ '*95&,'< A *$8.' %$- -'21&2&%$%/- %/ 1+%/0/*+&5$%' ,'+4'5/50/ 5$- %1$- ($-/- > %/5'+&5$%$ ,'/(&,&/50/ %/ %&-0*&1&6.'

  • 8/19/2019 Controle de qualidade em Radiofármacos

    5/8

    D/--$ ('*+$ $ -/4$*$6.' %/ M'O#? 4*/-/50/ ,'+' &+41*/8$ /+ /21$0'- %/

     N$+T,O# 4'%/ -/* */$2&8$%$ 4'* /0*$6.' 2731&%'2731&%' ,'+ +/0&2 /0&2 ,/0'5$ /

    )91$@ -/5%' ' 4*&+/&*' /0*$7%' 5$ ($-/ '*95&,$< A ,*'+$0'9*$(&$ 2731&%$ $20$ 4*/--.'

    CLAE 4*'+'=/ $ -/4$*$6.' %/ -1-05,&$- 4'* -1$ %&-0*&1&6.' /50*/ $ ($-/

    /-0$,&'5)*&$ $%-'*=/50/ / $ ($-/ +=/2 /21/50/@ 4'--1&5%' 1+$ $20$ */-'216.' /

    *$4&%/8 %/ -/4$*$6.'< A %/-0&2$6.' 4'--&&2&0$ $ -/4$*$6.' %/ ,'+4'-0'- ,'+ %&(/*/50/-

     4*/--/- %/ =$4'*< O ,'+4'-0' ,'+ +$&'* 4*/--.' %/ =$4'* %/-0&2$*) 4*&+/&*'< E+

    */$9/50/- 4$*$ &'%/0$6.' %/ -1-05,&$-@ ' &'%/0' /,/%/50/@ 4'%/ -/* '&%$%' $ &'%' /

    -/4$*$%' 4'* %/-0&2$6.'<

    2.%- Controle de qualidade &iol'(i#o

    O ,'50*'2/ &'29&,' /5='2=/ 31$0*' %/0/*+&5$6/-< A /-0/*&2&%$%/@ ,'5%&6.'(15%$+/50$2 4$*$ 0'%$ 4*/4$*$6.' %/ 1-' 4$*/50/*$2@ 4'%/ -/* '0&%$ ,'+ $10',2$=$9/+

    %$ 4*/4$*$6.' *$%&'($*+$,10&,$ =$4'* $ "" C $ "W 4-& " X ! +&5@ -/5%' =)2&%$

    $4/5$- 4$*$ -'216/- $31'-$- / /-0)=/&- $' ,$2'* +T,O#?"@ KG$?,&0*$0' %/ 9)2&'

    / """I5C2< A- 4*/4$*$6/- 2&4'(72&,$- / *$%&'()*+$,'- 0/*+'2)/&-@ 0$&- ,'+' $-

     4*'0/75$- &'%/0$%$-@ 5.' 4'%/+ -/* $10',2$=$%$-< A $10',2$=$9/+ 0$+>+ 5.' >

    10&2&8$%$ 4$*$ *$%&'51,27%/'- %/ =&%$ ,1*0$@ 0$&- ,'+'"WF@ 4'*31/ /-0/ +>0'%' > +1&0'

    %/+'*$%'< P$*$ *$%&'51,27%/'- %/ =&%$ ,1*0$ / *$%&'()*+$,'- 0/*+'2)/&- -.' 10&2&8$%'-$ (&20*$6.' 4'* +/+*$5$ +&2&4'*/ !@ + / $ &**$%&$6.' 9$+$<

    P&*9/5'- 4'2&--$,$*7%/'- '1 4*'0/75$- 4*'%18&%$- 4/2' +/0$'2&-+' %/

    +&,*''*9$5&-+'- %/=/+ /-0$* $1-/50/- /+ 4*/4$*$6/- &5/0)=/&- ,'+ ='21+/- %/

    $%+&5&-0*$6.' +$&'*/- 31/ ! +2 '1 /+ ='21+/- +/5'*/- $%+&5&-0*$%'- 4'* =&$

    &50*$0/,$2< E--$- -1-05,&$- -.' /+ -1$ +$&'*&$ /5%'0'&5$- %/ !@! X " + %/

    0$+$5;' / /+ 9/*$2 -.' -'2=/&- / /-0)=/&- $' ,$2'*< Q1$5%' $%+&5&-0*$%'- '- 4&*9/5'-

     4*'%18/+ -&50'+$- %/ (/*/@ 2/1,'4/5&$@ %'* %/ ,$/6$@ %&2$0$6.' %/ 414&2$- 31/ 4'%/+

    -/ %/-/5='2=/* /+ 4$,&/50/- %/ ! +&5 $0> ; $4- $ $%+&5&-0*$6.'< E&-0/+ %'&-

    +>0'%'- 4$*$ -1$ %/0/*+&5$6.'< O +>0'%' USP / ' 0/-0/ LAL< O 4*&+/&*' $-/&$?-/ 5$

    */-4'-0$ (/*&2 %/ ,'/2;'-@ 4'* $%+&5&-0*$6.' &50*$=/5'-$ %'- *$%&'()*+$,'- $ -/*/+

    0/-0$%'-< N/--/ 0/-0/ 5.' 4'%/+ -/* 10&2&8$%$- -1-05,&$- 31/ &50/*(/*/+ 5$ */-4'-0$

    ($*+$,'29&,$ %'- ,'/2;'-@ $--&+ ,'+' ,/*0'- ;'*+5&'-@ %*'9$- / *$%&'()*+$,'- %/

    $20'- 57=/&- %/ $0&=&%$%/< O 0/-0/ LAL L&-$%' %/ A+/,&0'- %/ L&+121- 10&2&8$?-/ %$-

     4*'0/75$- '0&%$- $0*$=>- %$ 2&-/ %/ $+/,&0'- %/ 2&+121- 1+ 0&4' %/ ,$*$591/' 31/

    */$9/+ ,'+ $- /5%'0'&5$-@ ('*+$5%' 1+ 9/2< E-0$ */$6.' /58&+)0&,$ %/4/5%/ %$

  • 8/19/2019 Controle de qualidade em Radiofármacos

    6/8

    0/+4/*$01*$@ PH / ,'5,/50*$6.' %$- /5%'0'&5$-@ 4'%/5%' %/+'*$* %/ " X ! +&5@

    %/4/5%/5%' %$ ,'5,/50*$6.' %/ 4&*9/5'-< A- /5%'0'&5$- 4'%/+ -/* $--&+

    %/0/*+&5$%$- 31$50&0$0&=$+/50/ 4'* ,'2'*&+/0*&$ '1 01*&%&+/0*&$@ ,'+ '$

    -/5-&&2&%$%/@ *$4&%/8@ / 4*$0&,&%$%/@ 0'*5$5%' 4'--7=/2 $ %/0/*+&5$6.' %/ 4&*9/5'- /+

    +$0/*&$&- ;&4' '1 ;&4/*0/*+&8$50/-@ '1 +/-+' 4*'%10'- *$%&'$0&='- %/ ,1*0' 0/+4' %/

    =&%$< E-0$ */$6.' 5.' 4'%/ -/* 10&2&8$%$ /+ 4*/-/56$ %/ &5&&%'*/- /58&+)0&,'- '1

    $9/50/- %/-5$01*$50/- %/ 4*'0/75$-<

    A &'%&-0*&1&6.' > 10&2&8$%$ 4$*$ $=$2&$6.' %' ,'+4'*0$+/50' &5 =&=' %/ 1+

    *$%&'()*+$,'@ $50/- %$ -1$ $%+&5&-0*$6.' $ 1+ 4$,&/50/< E-0) */2$,&'5$%$ $ 41*/8$

    *$%&'317+&,$@ 4'&- &+41*/8$- *$%&'317+&,$- 4'%/+ &5%18&* $20/*$6/- 5$ *'0$ %/

    %&-0*&1&6.'< E--$ &'%&-0*&1&6$' 4'%/ -/* /(/01$%$ 4'* 0>,5&,$- 5.' &5=$-&=$-

    */$2&8$6.' %/ &+$9/5- '1 0>,5&,$- &5=$-&=$-@ /5='2=/5%' ' -$,*&(7,&' %/ $5&+$&- /

    +/%&%$ %$ *$%&'$0&=&%$%/ ,'5,/50*$%$ 5'- *9.'- / 0/,&%'- %&--/,$%'-< O- */-120$%'-

     4'%/+ -/* /4*/--'- ,'+' ATI '1 ATI9< $ 0'&,&%$%/ %'- *$%&'()*+$,'- $50/- %/

    -1$ $%+&5&-0*$6.' /+ ;1+$5'- 0$+>+ %/=/ -/* %/0/*+&5$%$ / -1$ %'-/ %/ -/91*$56$

    0/+ 31/ -/* /-0$/2/,&%$< E--/- 0/-0/- 4$*$ 0'&,&%$%/ -.' */$2&8$%'- /+ =)*&'- $5&+$&-

    %1*$50/ ? -/+$5$-< O- $5&+$&- -.' -$,*&(&,$%'- $ =)*&'- &50/*=$2'- %/ 0/+4' / 1+$

    $10'4-&$ %/0$2;$%$ %'- %&(/*/50/- *9.'- > */$2&8$%$ 4$*$ '-/*=$* +1%$56$-

     4$0'29&,$-< LD!! > $ %'-/ */31/*&%$ 4$*$ 4*'%18&* ! %/ +'*0$2&%$%/ /+ ! %&$-

    $4- $ $%+&5&-0*$6.' %' *$%&'()*+$,'@ /531$50' 31/ LD!! ? %'-/ */31/*&%$ 4$*$

     4*'%18&* ! %/ +'*0$2&%$%/ /+ ! %&$- $4- $ $%+&5&-0*$6.' %' *$%&'()*+$,'< P'* 

    +'0&='- %/ -/91*$56$@ $ 31$50&%$%/ $%+&5&-0*$%$ $' ;'+/+ %/=/ -/* "!! $ !! =/8/-

    +/5'* 31/ $ 10&2&8$%$ 5'- $5&+$&-<

     A /-0$&2&%$%/ %' *$%&'()*+$,' 0$+>+ %/=/ -/* %/0/*+&5$%$@ 4'&- %/=&%' $

    9*$5%/ =$*&/%$%/ /-0*101*$2 %/ -1-05,&$- 10&2&8$%$- ,'+' *$%&'()*+$,'- 4'%/+

    ','**/* %&(/*/50/- 0&4'- %/ */$6/- %/ %/,'+4'-&6.' %' 0&4' ;&%*2&-/@ '&?*/%16.' /$10'*$%&2&-/< O- 4*',/--'- %/ ;&%*2&-/ -.' $20/*$%'- 4*&5,&4$2+/50/ 4'* 0/+4/*$01*$ /

     4H@ /531$50' 31/ $ '&*/%16$' > $(/0$%$ 4/2$ ,'5,/50*$6.' %/ '&95&'@ 4*/-/56$ %/

    $9/50/- '&%$50/-@ 7'5- +/0)2&,'- / ($0'*/- $+&/50$&- 0$&- ,'+' $ 218< A '&%$6.'

    ','**/ &91$2+/50/ /+ -'216/- $31'-$- / 5.' $31'-$-@ / /+ $291+$ /0/5-.' +/-+' 5'

    /-0$%' -2&%'< P$*$ /=&0$* $ '&%$6.' */,'+/5%$?-/ ' $,'5%&,&'5$+/50' %'- 4*'%10'-

    /+ (*$-,'- /-,1*'- / $' $*&9' %$ 218< N$ %/,'+4'-&6.' 4'* $10'*$%&2&-/@ $ $6.' %$-

    *$%&$6/- /+&0&%$- 4/2'- *$%&'51,27%/'- 4'%/ 4*'+'=/* $ 9/*$6.' %/ *$%&,$&- 2&=*/- 31/ 4'%/+ */$9&* ,'+ ' *$%&'()*+$,' '1 '10*$- +'2>,12$- %' +/&'@ */%18&5%' $--&+ $

  • 8/19/2019 Controle de qualidade em Radiofármacos

    7/8

    /-0$&2&%$%/ %'- *$%&'()*+$,'-< P'* /--/ +'0&='@ 4'%/+ -/* 10&2&8$%'- $9/50/-

    /-0$&2&8$50/- ),&%' $-,*&,'@ $-,'*$0' %/ -%&'< N$ +/%&,&5$ 51,2/$* $ /-0$&2&%$%/

    %'- '9'- %/ */$0&='-@ 10&2&8$%'- 4$*$ +$*,$6.' &5-0$505/$ / &5 -&01 %/ *$%&'()*+$,'-@ >

    %/4/5%/50/ %$ ,'+4'-&6.' %/ -/1 4*/,1*-'* 5.' +$*,$%'@ 31/ %/=/ -/* 1+$ -1-05,&$

    */-&-0/50/ $ %/9*$%$6.' (7-&,$ / 317+&,$< C$%$ ,'+4'5/50/ %$ 4*/4$*$6.' %'

    *$%&'()*+$,' / ($0'*/- $+&/50$&- 0$&- ,'+' 218@ 0/+4/*$01*$@ O@ CO / 1+&%$%/

     4'%/+ &5(21/5,&$* 5$ /-0$&2&%$%/< N/--/- '9'- $ ,'5-/*=$6.' %$ 4*'4*&/%$%/ */%10'*$

    %' S5C2 > 1+ ($0'* %/0/*+&5$50/ %$ /-0$&2&%$%/@ -/5%' +$50&%$ 4'* 1+$ $0+'-(/*$ %/

     N<

    %- CONCLUSÃO

    A //,16.' %'- ,'50*'2/- %/ 31$2&%$%/ %'- *$%&'()*+$,'- $%/31$%$+/50/ &*)

     4/*+&0&* +&5&+&8$* '1 +/-+' $'2&* $ 4'--&&2&%$%/ %/ 31/ /(/&0'- &5%/-/)=/&- -/$+

    '-/*=$%'- 5'- 4*',/%&+/50'- ,275&,'- %/ +/%&,&5$ 51,2/$*< M$&- $&5%$@ $1%$ $

    ,'5-'2&%$* '- 4*',/%&+/50'- %/ *$%&'($*+),&$@ &+4*/-,&5%7=/&- 4$*$ $ /2/=$%$

    &5',1&%$%/ %'- /$+/- /+ +/%&,&5$ 51,2/$*<

     

  • 8/19/2019 Controle de qualidade em Radiofármacos

    8/8

     )I)LIO*RA+IA

    E$*2[ PJ \ S'%// BD< P*&5,&42/- $5% 4*$0&,/ '( 51,2/$* +/%&,&5/< /% M'-[ Y/$* 

    B'']@ I5,@ L'5%'5@ "<

    O^15^$55/ A@ P$0/2 M $5% S$%/] S< T;/ H$5%''] '( R$%&'4;$*+$,/10&,$2-<

    C;$4+$5 $5% H$22 M/%&,$2@ M$%*$-@ "<

    S$;$ GB< F15%$+/50$2- '( N1,2/$* P;$*+$,[< *% N/^ Y'*]: S4*&59/*?V/*2$9@

    "W<